Top Markets
#1 Black Phoenix Black Phoenix +742.82%
#2 Beam Beam +37.06%
#3 Bless Bless +18.81%
#4 THORChain THORChain +18.49%
#5 SAFEcoin SAFEcoin +17.39%
#6 TENDIES TENDIES +15.64%
#7 EfficientFrontier EfficientFrontier +15.43%
#8 MiL.k Alliance MiL.k Alliance +14.60%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +14.31%
#10 THORChain Yield THORChain Yield +13.92%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
LigaChem Biosciences Inc. LigaChem Biosciences Inc.

LigaChem Biosciences Inc.

141080
Rank in Stocks #5687
LigaChem Biosciences, Inc. specializes in the development and manufacturing of... LigaChem Biosciences, Inc. specializes in the development and manufacturing of a broad spectrum of medical solutions, encompassing pharmaceuticals, medical devices, and essential healthcare supplies. Their extensive product offerings include various therapeutic agents such as antibiotics, anti-coagulants, and oncology treatments, alongside cutting-edge antibody-drug conjugates and protein-drug conjugates. Established on May 2, 2006, the company's headquarters are situated in Daejeon, South Korea.
Share Price
$68.87
Market Cap
$2.51B
Change (1 day)
1.32%
Change (1 year)
-35.79%
Country
KR
Trade LigaChem Biosciences Inc. (141080)

Category

Healthcare
Revenue for LigaChem Biosciences Inc. (141080)
Revenue in Aug 2026 TTM: 0
According to LigaChem Biosciences Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for LigaChem Biosciences Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH